Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Share-based Compensation (2019 - 2025)

Historic Share-based Compensation for InfuSystem Holdings (INFU) over the last 11 years, with Q3 2025 value amounting to $1.3 million.

  • InfuSystem Holdings' Share-based Compensation rose 827.19% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 606.46%. This contributed to the annual value of $4.5 million for FY2024, which is 947.47% up from last year.
  • InfuSystem Holdings' Share-based Compensation amounted to $1.3 million in Q3 2025, which was up 827.19% from $661000.0 recorded in Q2 2025.
  • InfuSystem Holdings' Share-based Compensation's 5-year high stood at $2.0 million during Q3 2021, with a 5-year trough of $589000.0 in Q4 2022.
  • Its 5-year average for Share-based Compensation is $1.2 million, with a median of $1.1 million in 2025.
  • In the last 5 years, InfuSystem Holdings' Share-based Compensation surged by 69368.93% in 2021 and then plummeted by 5915.4% in 2022.
  • Over the past 5 years, InfuSystem Holdings' Share-based Compensation (Quarter) stood at $1.4 million in 2021, then plummeted by 59.15% to $589000.0 in 2022, then surged by 116.47% to $1.3 million in 2023, then fell by 7.14% to $1.2 million in 2024, then grew by 11.66% to $1.3 million in 2025.
  • Its Share-based Compensation was $1.3 million in Q3 2025, compared to $661000.0 in Q2 2025 and $1.1 million in Q1 2025.